- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.05. | Daiichi Sankyo and Waiv partner for ADC biomarkers | ||
| 07.05. | Halozyme and Oruka sign agreement for Hypercon technology | ||
| 06.05. | Bayer looks to uphold Eylea legacy with $2.45bn Perfuse buyout | ||
| 06.05. | Citius raises $36.5m for Lymphir commercialisation | ||
| 06.05. | DDW 2026: key readouts from the conference | ||
| 06.05. | Arrowhead and Madrigal sign global licence for MASH RNAi therapy | ||
| 06.05. | MSD concludes Terns acquisition to expand CML pipeline | ||
| 05.05. | Madrigal outlays $1bn for Arrowhead's siRNA MASH asset | ||
| 05.05. | UCB doubles down on TCEs with $2.2bn Candid buyout | ||
| 05.05. | Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara | ||
| 05.05. | Latus Bio secures $97m in funding to boost gene therapy access | ||
| 04.05. | Arrowhead's Redemplo secures Australian TGA approval for FCS therapy | ||
| 04.05. | Novo Nordisk to launch Ozempic for type 2 diabetes in US | ||
| 01.05. | Axsome receives FDA approval for Auvelity to treat Alzheimer's agitation | ||
| 01.05. | Eli Lilly lifts 2026 revenue guidance as Q1 marks dominant opening | ||
| 01.05. | BMS brings the buzz around late-stage readouts amid a so-so Q1 | ||
| 01.05. | LEO Pharma to acquire gene therapy company Replay | ||
| 30.04. | Chiesi widens rare disease portfolio with $1.9bn KalVista buyout | ||
| 30.04. | Teva signs off $900m Emalex buyout amid strategic pipeline boosting ploy | ||
| 30.04. | Ray Therapeutics receives EMA PRIME status for gene therapy | ||
| 30.04. | Regeneron Q1 2026 net income falls 10% to $727m | ||
| 29.04. | Pfizer protects $6.4bn heart disease blockbuster from generics, for now | ||
| 29.04. | Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact | ||
| 29.04. | Novartis' Q1 sales miss hints at industry's utilisation of M&A remedies | ||
| 29.04. | Arcera and Fosun sign MoU for neuroscience innovation |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.